Consequently, PTEN acts as a negative regulator of the PI3K/Akt pathway [158,159], and mutations or loss of its tumor suppressor function are linked to the development of various cancers [158,159], including glioblastoma [160,161]. The gene discussed is AKT1; the disease is neoplasm.